Association between event-free survival and overall survival in early-stage triple-negative breast cancer - supplementary material

Table S1. Key characteristics of single-arm trials and cohort studiesTable S2. Base case and sensitivity analyses of individual-level associationTable S3. Predicted results for the trials with immunotherapy using the model without fixed intercept based on non-immunotherapy trialsTable S4. Validation of individual level associationTable S5. Search strategy for the target literature reviewFigure S1. PRISMA chartFigure S2. Trial-level association between EFS and OS excluding immunotherapy trialsFigure S3. Validation of trial-level association